TOPLINE: The introduction of highly effective modulator (elexacaftor/tezacaftor/ivacaftor) therapy improved the disease trajectory of cystic fibrosis (CF). However, its benefits were less pronounced for lung transplant candidates of Black or Hispanic ethnicity than for those of White ethnicity. METHODOLOGY: Researchers evaluated the differences in lung transplantation outcomes by race/ethnicity in patients with CF using data ...
.png)
2488 Grand Concourse, suite 314, Bronx NY 10458
+1786-550-1661
info@holdingsolutioninc.com
Copyright © 2023 holdingsolutioninc. All Rights Reserved
